Found: 23
Select item for more details and to access through your institution.
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1.
- Published in:
- Advanced Science, 2024, v. 11, n. 26, p. 1, doi. 10.1002/advs.202309268
- By:
- Publication type:
- Article
Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48514-8
- By:
- Publication type:
- Article
Antibody-directed evolution reveals a mechanism for enhanced neutralization at the HIV-1 fusion peptide site.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42098-5
- By:
- Publication type:
- Article
Development of Neutralization Breadth against Diverse HIV‐1 by Increasing Ab–Ag Interface on V2.
- Published in:
- Advanced Science, 2022, v. 9, n. 15, p. 1, doi. 10.1002/advs.202200063
- By:
- Publication type:
- Article
Extended antibody-framework-to-antigen distance observed exclusively with broad HIV-1-neutralizing antibodies recognizing glycan-dense surfaces.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26579-z
- By:
- Publication type:
- Article
Improvement of antibody functionality by structure-guided paratope engraftment.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-019-08658-4
- By:
- Publication type:
- Article
Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. 1, doi. 10.1038/s41467-018-07851-1
- By:
- Publication type:
- Article
Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-03335-4
- By:
- Publication type:
- Article
Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 406, p. 1, doi. 10.1126/scitranslmed.aal1321
- By:
- Publication type:
- Article
Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 381, p. 1, doi. 10.1126/scitranslmed.aai7514
- By:
- Publication type:
- Article
Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting.
- Published in:
- PLoS Pathogens, 2017, v. 13, n. 1, p. 1, doi. 10.1371/journal.ppat.1006148
- By:
- Publication type:
- Article
Potent and broad HIV-neutralizing antibodies in memory B cells and plasma.
- Published in:
- Science Immunology, 2017, v. 2, n. 7, p. 1, doi. 10.1126/sciimmunol.aal2200
- By:
- Publication type:
- Article
Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 3, p. 1, doi. 10.1371/journal.ppat.1005520
- By:
- Publication type:
- Article
Structure and immune recognition of trimeric pre-fusion HIV-1 Env.
- Published in:
- Nature, 2014, v. 514, n. 7523, p. 455, doi. 10.1038/nature13808
- By:
- Publication type:
- Article
Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.
- Published in:
- Nature, 2014, v. 509, n. 7498, p. 55, doi. 10.1038/nature13036
- By:
- Publication type:
- Article
Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV.
- Published in:
- Nature, 2014, v. 505, n. 7484, p. 502, doi. 10.1038/nature12893
- By:
- Publication type:
- Article
Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16.
- Published in:
- Nature Structural & Molecular Biology, 2013, v. 20, n. 7, p. 804, doi. 10.1038/nsmb.2600
- By:
- Publication type:
- Article
N332-Directed Broadly Neutralizing Antibodies Use Diverse Modes of HIV-1 Recognition: Inferences from Heavy-Light Chain Complementation of Function.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0055701
- By:
- Publication type:
- Article
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody.
- Published in:
- Nature, 2012, v. 491, n. 7424, p. 406, doi. 10.1038/nature11544
- By:
- Publication type:
- Article
Broad HIV-1 neutralization mediated by CD4-binding site antibodies.
- Published in:
- Nature Medicine, 2007, v. 13, n. 9, p. 1032, doi. 10.1038/nm1624
- By:
- Publication type:
- Article
The gene product Murr1 restricts HIV-1 replication in resting CD4<sup>+</sup> lymphocytes.
- Published in:
- Nature, 2003, v. 426, n. 6968, p. 853, doi. 10.1038/nature02171
- By:
- Publication type:
- Article
Preparation of Clinical-Grade Recombinant Canarypox--Human Immunodeficiency Virus Vaccine--Loaded Human Dendritic Cells.
- Published in:
- Journal of Infectious Diseases, 2002, v. 186, n. 9, p. 1242, doi. 10.1086/344302
- By:
- Publication type:
- Article
Human skin Langerhans cells are targets of dengue virus infection.
- Published in:
- Nature Medicine, 2000, v. 6, n. 7, p. 816, doi. 10.1038/77553
- By:
- Publication type:
- Article